Pharma company payments revealed


Pharmacists are among health professionals getting payments from pharma companies… but it’s peanuts compared to that pocketed by GPs and nurses

An exclusive report by ABC medical reporter Sophie Scott and journalist Alison Branley has revealed that pharmaceutical companies spent more than $2 million on allied health professionals in 2016-7.

These funds were paid for services such as consultant fees, educational events including overseas conferences, and guest speaking roles.

ABC reporters analysed information from a new database operated by Professor Lisa Bero and her team at the Charles Perkins Centre at the University of Sydney. They found that pharmaceutical companies paid $1,640,079.23 to nurses during the one-year period (plus another $62,829.53 for nurse practitioners).

As a group, pharmacists were the runners-up, earning $266,869 from the companies in 280 payments. The biggest spender on pharmacy was Pfizer, which spent $72,634.

“Some of the highest individual earners included a nurse practitioner who received $17,662 to go to ‘an independent meeting overseas’, a nurse who was paid $11,408 for a similar trip abroad, a Victorian pharmacist who got $7,687 for a ‘consulting service’ and a NSW physio who was paid $5,250 for being on an ‘advisory board or committee meeting’,” the journalists write.

However, the amount paid to allied health professionals pales in comparison to that paid to general physicians.

This group received 12,591 payments adding up to over $21 million.

“While it has long been known that doctors and specialists take money from the corporations, it is the first time it has been made clear allied health professionals are also receiving payments,” the journalists write.

“Many of the drug companies paid allied health workers who specialised in conditions that aligned with their product range.”

Pharmacy Guild of Australia – Victorian Branch president Anthony Tassone told the ABC that he has attended advisory board meetings, for which payment only compensates pharmacists for time spent.

“I have been in a range of these and it’s really just giving feedback to make sure they don’t stuff up their packaging and don’t do stupid things with their educational material,” Mr Tassone said.

Such payments should not be considered a kickback, he said, as such services were in the interest of achieving best outcomes.

Read the full report here.

Previous Medicines Management 2017 hits Sydney
Next Searching for meaning: one pharmacist's Kokoda lessons

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.


  1. Jarrod McMaugh

    This list has been published for a while now, although I guess it needed the mainstream media to see it for it to become a news item.

    I’m on this list – I’ve provided education sessions to pharmacists for pharmaceutical companies, and I have consulted for companies who have wanted advice on new products being launched, or for submissions to the TGA on scheduling.

    The point is, this shouldn’t be hard information to find. All of mine are included in my Linkedin profile, and most importantly if I’m talking on a topic (including online) for which I’ve been paid a consulting fee in the past, I ensure that people know this. Conflicts of interest arise when this information isn’t made clear and available.

  2. JimT

    welcome to the real world……I think it’s called advertising….derr!!! must be a slow news week

Leave a reply